R
René Valéro
Researcher at Aix-Marseille University
Publications - 98
Citations - 2623
René Valéro is an academic researcher from Aix-Marseille University. The author has contributed to research in topics: Diabetes mellitus & Insulin resistance. The author has an hindex of 23, co-authored 90 publications receiving 2016 citations. Previous affiliations of René Valéro include French Institute of Health and Medical Research & University of Toronto.
Papers
More filters
Journal ArticleDOI
Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli
Matthieu Million,Emmanouil Angelakis,Marie Maraninchi,Mireille Henry,Roch Giorgi,René Valéro,B. Vialettes,Didier Raoult +7 more
TL;DR: The findings confirm the specificity of the obese microbiota and emphasize the correlation between the concentration of certain Lactobacillus species and obesity.
Journal ArticleDOI
The Type and the Position of HNF1A Mutation Modulate Age at Diagnosis of Diabetes in Patients with Maturity-Onset Diabetes of the Young (MODY)-3
Christine Bellanné-Chantelot,Claire Carette,Jean-Pierre Riveline,René Valéro,Jean-François Gautier,Etienne Larger,Yves Reznik,Pierre-Henri Ducluzeau,A. Sola,Agnès Hartemann-Heurtier,Pierre B. A. Lecomte,Lucy Chaillous,Marie Laloi-Michelin,Jean-Marie Wilhem,Pierre Cuny,Françoise Duron,Bruno Guerci,Nathalie Jeandidier,Helen Mosnier-Pudar,Michel Assayag,Danièle Dubois-Laforgue,Gilberto Velho,José Timsit +22 more
TL;DR: Data show that part of the variability of the clinical expression in MODY3 patients may be explained by the type and the location of HNF1A mutations, which should be considered in studies for the search of additional modifier genetic factors.
Journal ArticleDOI
Hyperinsulinemia Is Associated With Increased Production Rate of Intestinal Apolipoprotein B-48–Containing Lipoproteins in Humans
TL;DR: These are the first human data to conclusively demonstrate that intestinal apoB-48–containing triglyceride-rich lipoprotein PR is increased in hyperinsulinemic, insulin-resistant humans.
Journal ArticleDOI
Anti-PD1 Pembrolizumab Can Induce Exceptional Fulminant Type 1 Diabetes
C. Gaudy,Céline Clévy,Sandrine Monestier,Noémie Dubois,Yanis Préau,Stéphanie Mallet,Marie-Aleth Richard,Jean-Jacques Grob,René Valéro,René Valéro,Sophie Béliard +10 more
TL;DR: A 44-year-old Caucasian woman with no history of diabetes was admitted to the emergency department in 2014 for vomiting and confusion, with polyuria, polydipsia, and a very recent weight loss, leading to the unusual diagnosis of fulminant type 1 diabetes.
Journal ArticleDOI
Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and Switzerland
M. Benzaquen,Luca Borradori,Philippe Berbis,Simone Cazzaniga,Simone Cazzaniga,René Valéro,Marie-Aleth Richard,Laurence Feldmeyer +7 more
TL;DR: DPP4is, especially vildagliptin, are associated with an increased risk for development of BP, and their use needs to be carefully evaluated, particularly in high‐risk patients, such as males and those age 80 years or older.